Kumar Sanjeev, Kumar Ashok, Pal Ajay Kumar, Ahirwar Suresh Kumar, Kumar Suresh, Ahmad Arshad
Department of Surgery, King George Medical University, Lucknow, Uttar Pradesh 226003 India.
Department of Skin and Veneral Diseases, RML Institute of Medical Sciences, Lucknow, U.P India.
Indian J Thorac Cardiovasc Surg. 2019 Jan;35(1):36-40. doi: 10.1007/s12055-018-0724-1. Epub 2018 Sep 20.
Chronic pleural empyema is usually a consequence of in adequate treatment of acute pleural empyema. The incidence of tubercular and post-intervention empyema has increased in underdeveloped or developing countries adding to economic burden on the society. We have performed a retrospective analysis on role of intervention in chronic empyema to improve respiratory functional outcomes.
We retrospectively reviewed data of 115 patients of chronic tubercular and parapneumonic empyema thoracis to evaluate change in functional outcome parameters based on their treatment modalities during follow-up in department of surgery, King George's Medical University, Lucknow, India. Accordingly, four groups were made-group 1 (tube thoracostomy), group 2 (decortication by video-assisted thoracoscopic surgery (VATS)), group 3 (decortication by open thoracotomy), and group 4 (window thoracostomy followed by thoracomyoplasty).
Significant improvement was noted in forced expiratory volume in one second (FEV1)% and forced vital capacity (FVC)% in all groups. In spirometry, percent change in mean FEV1 from pre-intervention to post-intervention was increase of 55.4%, 38.3%, 47.2, and 59.21% in group 1, group 2, group 3, and group 4 respectively, and percent change in mean FVC from pre-intervention to post-intervention was increase of 53.30%, 38.11%, 51.23, and 54.21% in group 1, group 2, group 3, and group 4 respectively.
Our study showed that a significant increase was observed in FVC and FEV1 from pre to post among all the groups. Comparable improvement of functional outcomes with non-operative intervention in properly selected patients can be achieved.
慢性脓胸通常是急性脓胸治疗不充分的结果。在不发达国家或发展中国家,结核性脓胸和介入治疗后脓胸的发病率有所增加,给社会带来了经济负担。我们对介入治疗在慢性脓胸中的作用进行了回顾性分析,以改善呼吸功能结局。
我们回顾性分析了印度勒克瑙乔治国王医科大学外科115例慢性结核性和肺炎旁脓胸患者的数据,根据他们在随访期间的治疗方式评估功能结局参数的变化。据此,分为四组:第1组(胸腔闭式引流术)、第2组(电视辅助胸腔镜手术(VATS)剥脱术)、第3组(开胸剥脱术)和第4组(胸廓开窗术加胸廓成形术)。
所有组的一秒用力呼气容积(FEV1)%和用力肺活量(FVC)%均有显著改善。在肺功能测定中,第1组、第2组、第3组和第4组从干预前到干预后平均FEV1的百分比变化分别增加了55.4%、38.3%、47.2%和59.21%,从干预前到干预后平均FVC的百分比变化分别增加了53.30%、38.11%、51.23%和54.21%。
我们的研究表明,所有组从术前到术后FVC和FEV1均有显著增加。在适当选择的患者中,非手术干预可实现类似的功能结局改善。